Outlook Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-38.8M | $-53.3M | $-47.4M |
| Depreciation & Amortization | $2.7M | $2.4M | $1.8M |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | $8.6M | $12.5M | $11.2M |
| Net Cash from Operating Activities | $-15.5M | $-45.5M | $-27.5M |
| Investing Activities | |||
| Capital Expenditures | $292.1K | $1.1M | $8.8M |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-292.1K | — | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $16.6M | — | — |
| Net Change in Cash | $833.6K | $-6.7M | $6.7M |
| Free Cash Flow | $-15.8M | $-46.6M | $-36.3M |